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Abstract 
Introduction 
Increased vascular stiffness is a risk factor for mortality. We wished to 
determine whether changes in vascular stiffness are associated with changes in 
bone mineral density (BMD) in peritoneal dialysis (PD) patients.  
Methods 
We measured vascular stiffness by aortic pulse wave velocity (aPWV), and BMD 
by dual electron absorptiometry (DXA) scanning and compared T scores to 
compensate for differences in patient ages and gender. 
Results 
24 patients had repeat aPWV measurements and DXA scans, median 12 .4 
months apart. aPWV decreased in 15 and increased in 9. As there were more 
women in the group with an increase in aPWV we used gender adjusted DXA T 
scores Total body T scores fell in both groups, but median T scores remained 
positive for those with an increase in aPWV, whereas negative T scores on both 
scans for those with a decrease in or stable aPWV. Lumbar spine T scores fell in 
those with a reduction in aPWV (-1.6 (-2.4 to 0.6) to -2.1 (-2.4 to 0.3), p<0.05, 
whereas there was no significant decrease in those with an increase in aPWV (-
0.5(-1.1 to 0.15) to -0.7(-1.7 to 0.6). There were no changes in femoral neck T 
scores. 
Conclusions 
Our study reinforces the hypothesis of a link between bone disease and 
vascular disease in dialysis patients. Lumbar spine DXA includes imaging of the 
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aorta and will include aortic calcification, and as such a reduction in lumbar spine 
T score without a change in femoral neck T score suggests a reduction in aortic 
calcification. Although our study requires additional confirmation, our data 
would suggest that changes in aPWV could be used as a surrogate for changes in 
vascular calcification in the investigation of interventions designed to reduce 
vascular calcification.  
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Background 
 
 In the general population vascular calcification has been shown to be a 
risk factor for mortality and inversely related to bone mineral density (BMD) 
measured by dual-energy X-ray absorptiometry (DXA) [1]. Vascular calcification 
increases arterial stiffness, which can reliably be measured by pulse wave 
velocity (PWV), and aortic stiffness is an independent risk factor for 
cardiovascular mortality [2].  
 Cross-sectional studies in dialysis patients have reported PWV is 
positively associated with lumbar spine BMD, and negatively with femoral neck 
BMD [3,4]. We wished to determine whether changes in PWV in peritoneal 
dialysis (PD) were associated with changes in BMD by DXA. 
 
Patients and methods 
PWV was measured prospectively in a cross-sectional cohort of PD 
patients attending for peritoneal membrane testing. Repeat PWV measurements 
were made in 66 patients, median 12.4 months apart, and 24 had repeat whole 
body DXA scans (Hologic QDR Discovery W (S/N47096), APEX software version 
4.5.2.1) with T scores calculated from the National Health and Nutrition 
Examination Survey (NHANES) III population data set. 
Patient demographic data, and medications were retrieved from 
electronic medical records. PD adequacy as the weekly urea clearance (Kt/Vurea) 
from 24-hour urine and peritoneal dialysate effluent collections. The daily 
calcium balance  was estimated as the difference between the amount of calcium 
5 
 
in the fresh daily dialysates and the calcium content of 24-hour spent dialysate 
and 24-urine collections. Apart from icodextrin, all dialysate solutions contained 
1.25 mmol/L calcium. Biochemical tests were measured by standard methods 
(Roche Integra, Roche diagnostics, Lewes, UK). Body composition was 
determined by multifrequency bioelectrical impedance assessments (MFBIA) 
(InBody 720, Seoul, South Korea) using a standardised protocol [5]. 
We measured aortic-brachial pulse wave velocity using the Tensio Clinic 
Arteriograph (TensioMed Kft., Budapest, Hungary) which has been validated 
against direct invasive measurements [6]. In keeping with standard practice 
aortic PWV (aPWV) measurements were corrected for heart rate 
 
Statistical analysis 
 Statistical analysis was performed using standard analyses;D’Agostino-
Pearson normality test along with t test and  paired t test, Mann Whitney U test 
and Wilcoxon rank sum pair test, as appropriate, andthe Spearman rank sum was 
used for univariate correlation (Graph Pad Prism version 7.0, Graph Pad, San 
Diego, USA) and SPSS version 24 (IBM corporation, Armonk, New York, USA). 
Statistical significance was taken at or below the 5% level. 
 
Ethics 
All procedures performed in studies involving human participants were in 
accordance with the ethical standards of the institutional and/or national 
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research committee (National research ethics committee 129559) and with the 
1964 Helsinki declaration and its later amendments or comparable ethical 
standards. Written valid informed consent was obtained from all individual 
participants included in the study, and all patient data appropriately anonymised. 
 
Results 
We divided patients into those who had an increase in aPWV, median 1.6 (0.5-
2.9) cm/s and those who had a fall in aPWV, median -1.2 (-2.7 to -0.6) cm/s 
(Table 1), measured a median of 12.4 months apart, when patients reattended 
for their annual assessment of peritoneal membrane assessment. Patients with a 
fall in aPWV initially had higher aPWV, but there was no statistical association 
between the starting aPWV and the change in aPWV. (r=0.11-.0, p=0.6),  more 
women had an increase in aPWV (X2=5.2, p=0.022). However, there was no 
difference in mean arterial blood pressure, or prescription of anti-hypertensive 
medications. There were no differences in weekly peritoneal and urinary urea 
clearances, or urine volumes. Serum calcium and phosphate, and parathyroid 
hormone were not different, as was prescription of calcium containing phosphate 
binders. Native vitamin D3 concentrations were initially lower in those patients 
starting with a higher aPWV, and then increased as aPWV fell. Peritoneal and 
urinary calcium losses between groups were similar. On DXA scanning total body 
bone mineral content (BMC), and BMD fell in both groups (p<0.05). Although 
BMD fell in 80% of those with a fall in aPWV, there was no statistical 
difference in the change in BMD (table 1) or annualised change in BMD (-0.03 (-
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0.06 to -0.01) vs 0 (-0.08 to 0.03) g/cm2/year). As BMC and BMD vary with age 
and gender, we calculated T scores to enable comparison between patients. Total 
T scores fell in the group with increased aPWV (Figure 1). BMD and T scores of 
the lumbar spine only fell in those with a fall in aPWV. No patient was reported 
to have verterbral fractures. There were no changes in absolute femoral neck 
BMD or when annualised (0.01 (0-0.03) vs 0.01 (0-0.03) gm/cm2/year.or T scores 
There was no overall change in the ratio of extracellular water to total body 
water; 0.391±0.015 vs 0.394±0.06, p>0.05, and no statistical association between 
the change in ECW/TBW and aPWV (r=-0.19, p=0.40). 
 
Discussion 
Greater PWV and vascular calcification are both associated with an 
increased risk of mortality [1,2], and osteoporosis is a risk for increased 
arteriosclerotic vascular calcification [7]. Osteoporosis, arterial calcification 
and cardiovascular disease all share common risk factors, but also 
pathophysiological pathways linking vascular disease and osteoporosis [8].  
Previous cross- sectional studies in dialysis patients have reported an 
association between PWV and DXA BMD or T score [4,9]. Our study is the first 
to compare pairs of DXA scans and aPWV measurements. We chose to measure 
aPWV as this is a measure or aortic PWV, whereas other PWV devices measure a 
composite of carotid-aortic and femoral artery PWV. The prevalence of medial 
vascular calcification varies between arteries, being greater for the aorta 
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compared to the femoral artery, and the femoral artery greater than that of 
the carotid artery [10]. 
Aortic PWV fell in one group, who started with a greater initial aPWV. 
There was no effect of the change in aPWV and the initial aPWV. The reduction 
in aPWV in this group was not associated with differences in blood pressure 
control, ECW/TBW or anti-hypertensive prescriptions. Similarly, there were no 
differences in serum chemistries, or prescription of calcium containing binders, 
estimates of peritoneal and urinary calcium losses, or prescription of active 
vitamin D analogues. This group started with lower native vitamin D3 
concentrations, which were then supplemented in keeping with clinical policy of 
the centre, and previous reports have suggested that native vitamin D3 may play 
a role in preventing vascular calcification [11].  
Although DXA scanning has not been shown to be predictive of the type 
renal bone mineral disease, reduced BMD on DXA scanning is associated with 
increased fracture risk for kidney dialysis patients [12], and fracture risk is not 
only increased for peritoneal dialysis patients [13], but also with both greater 
over-all mortality and cardiovascular mortality [13,14]. 
Total body BMC was greater in the group with a fall in aPWV, but as this 
group contained more men, we reviewed T scores to overcome confounders of 
gender and age. Whereas the median T scores on DXA scans were negative for 
the group with a fall in aPWV, they were positive on both scans for those with 
an increase in aPWV. T scores were similar for the femoral neck for both 
groups, and did not change between scans.  
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However, T scores for the lumbar spine only fell in those with a reduction 
in aPWV. DXA scans of the lumbar spine include the aorta, and as such 
additionally measure aortic calcification. Thus, the fall in aPWV and lumbar spine 
T score could reflect a reduction in aortic calcification and thus a reduction in 
aortic stiffness as measured by aPWV, whereas there was no reduction in 
lumbar T score in those patients with an increase in aPWV. On the other hand, 
at the femoral neck which has no overlying artery there was no change in T 
score on repeat DXA scanning and no association between T score and aPWV. 
As such, our study supports previous reports of an association between PWV and 
vascular calcification [15], and more recent studies have shown that a reduction 
in vascular calcification following parathyroidectomy is associated with a 
reduction in vascular stiffness, measured by PWV [16].  
 We report a short-term study, as PWV tends to increase with patient 
age. There may be errors in PWV measurement, but to overcome these, all 
measurements were made by the same observer. Calcification of conduit 
arteries may reduce PWV, particularly when measuring PWV over a longer 
distance, such as brachial artery-ankle PWV [17]. To reduce this potential 
artefact, we restricted our measurements to aPWV. Recent studies have 
observed an association between the regulators of vascular calcification and 
PWV [18]. However we were only able to measure standard biochemical variables. 
Patients with chronic kidney disease have a much greater rate of 
increase in aortic stiffness, and a faster increase in aPWV compared to patients 
with normal kidney function 19]. Dialysis patients have disorders of bone and 
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mineral metabolism, resulting in greater risk of vascular calcification We report 
that a fall in aPWV in PD patients was associated with a fall in lumbar spine T 
score, which most likely reflects a reduction in the adjacent aortic calcification, 
reinforcing the hypothesis of a link between bone disease and vascular disease 
in dialysis patients. Although our study requires additional confirmation, our 
data would suggest that changes in aPWV could be used as a surrogate for 
changes in vascular calcification in the investigation of interventions designed to 
reduce vascular calcification.  
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Figure 1. T scores derived from dual electron absorptiometry (DXA) total body, 
lumbar spine and femoral neck bone mineral density. Median (interquartile range) 
* p<0.05, ** <0.01 second scan (T2) vs first scan (T1). Patients divided into those 
in whom aPWV did not increase (Stable) and those with an increase in aPWV. 
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Table 1. Peritoneal dialysis (PD) patients were divided to those who did not 
increase (Stable) aortic pulse wave velocity (aPWV) and those with an increase in 
aPWV. Dual electron absorptiometry (DXA), body mass index (BMI), skeletal 
muscle mass (SMM). Results expressed as integer, percentage, mean ±SD, 
median (interquartile range). * p <0.05 vs stable aPWV. 
 
variable Stable aPWV  Increased aPWV 
 First aPWV Follow-up First aPWV Follow-up 
number 15  9  
Gender (male) 12 (75%)  3 (33.3%)*  
Age years 51.5±14.4  43.8±11.2  
PD treatment months 24.6±21.1  25.8±16.9  
DXA scan interval 
months 
14.3(13.3-
20.5) 
 16.4(16.0-
18.6) 
 
aPWV m/s 9.6±3.1 9.0±2.0 6.9±2.1* 8.8±2.6 
Weight kg 72.7±17.5 72.7 ±17.4 73.8±16.0 72.6±16.1 
BMI kg/m2 24.9 ±4.6 25.0 ±4.4 28.0±3.7 27.3±3.1 
Weekly Kt/Vurea 1.93±0.47 1.90±0.66 1.99±0.49 1.96±0.66 
24-hour urine volume 
L/day 
0.98 (0.59-
1.16) 
0.82 (0.16-
1.07) 
0.64(.49-
0.77) 
0.49(0.1-
0.88) 
Icodextrin L/day 2.0 (0-2.5) 2.0 (0-2.5) 1.5(0.9-2.0) 1.8(0.7-2.8) 
Protein nitrogen 
appearance g/day 
0.91 ±0.17 0.96 ±24 0.84±0.26 0.82±0.30 
Net calcium loss 
mmol/day 
0.6 (0-1.6) 0.6(0.2-0.9)  0.3 (-0.8 to 
0.8 
0.7(-0.3 to 
1.0) 
Serum calcium mmol/L 2.31 ±0.19 2.28 ±0.16 2.42±0.10 2.39±0.14 
Serum phosphate 
mmol/L 
1.68±0.56 1.72±0.44 1.63±0.44 1.50±0.26 
Serum magnesium 
mmol/L 
0.82±0.14 0.86±0.2  0.95±0.20 0.91±0.27 
Parathyroid hormone 
pmol/L 
38 (20-80) 31 (19-67) 28(27-29) 24(15-31) 
25 OH Vitamin D3 
nmol/L 
64 (26-100) 87 (65-103) 82(78-109)* 82(67-91) 
Alkaline phosphatase 
U/L 
100 (83-151) 108 (89-
168) 
77(66-95) 75(65-99) 
Serum albumin g/L 38.1 ±3.8 37.9 ±3.3 40.8±3.9 39.6±2.5 
C reactive protein 
mg/L 
5 (2-22) 3 (2-3) 1(1-3) 3(1-6) 
Serum bicarbonate 
mmol/L 
24.9±3.0 23.9±3.0 24.7±2.9 24.0±3.3 
Serum creatinine 
umol/L 
847(359-
944) 
877(717-
1080) 
583(513-
701) 
700(546-
806) 
Haemoglobin g/L 103.7 ±16.0 103.6 ±8.7 114.8±16.3 107.6±13.2 
15 
 
Haemoglobin A1c 
mmol/mol 
35.5 (33.3-
44.3) 
36.6 (35.5-
41) 
35.5(34.4-
39.9) 
38.8(35.5-
41) 
Glucose mmol/L 5.6(5.2-7.1) 5.6(4.9-6.3) 5.2(4.7-5.4) 5.0(4.5-5.2) 
Ferritin ug/L 662 (353-
944) 
586 (408-
828) 
472(328-
714) 
561(368-
1064) 
Mean arterial blood 
pressure mmHg 
113.8 ±17.7 113.6±19.9 107.7±16.0 106.0±10.9 
Patients prescribed 
antihypertensives % 
60 73.3 88.9 66.7 
Number of classes of 
antihypertensives 
1 (0-1) 1 (0-2) 1 (1-1.5) 1 (0-1) 
Alphacalcidol 
prescribed ug/week 
0.75 (0-
1.75) 
0.75 (0-3.5) 0.75(0.25-
2.5) 
0.75(0.25-
3.25) 
Number of calcium 
binders/day 
0 (0-1) 0 (0-3)  0 (0-3.5) 0 (0-3) 
Total body bone 
mineral content g 
2559 ±531 2255±381 
±535 
2471±543 2225±482 
Total body bone 
mineral density g/cm2 
1.21 ±0.17 1.18 ±0.07 1.19±0.09 1.16±0.09 
Lumbar spine bone 
mineral density g/cm2 
0.917(826-
1.16) 
0.861(0.806-
1.16) 
1.06(0.955-
1.1) 
0.968(0.922-
1.14) 
Femoral neck bone 
mineral density g/cm2 
0.645(0.601-
0.733) 
0622(0.575-
0.774) 
0.608(0.542-
0.802) 
0.61(0.524-
0.776) 
 
 
 
 
 
 
 
 
 
 
